Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including: 

• Antiviral therapy with remdesivir 
• Dexamethasone and other systemic corticosteroids 
• Immunomodulators, such as JAK inhibitors or IL-6 inhibitors 
• Overviews of clinical trial data demonstrating how and when to use these therapies

Presenters:

Stephen Cantrill, MD, FACEP​
Associate Director and Medical Director (Retired) ​ 
Department of Emergency Medicine​ 
Denver Health Medical Center​ 
Associate Professor ​ 
Department of Emergency Medicine​ 
University of Colorado Health Sciences Center​ 
Denver, Colorado 

Rajesh T. Gandhi, MD​
Massachusetts General Hospital​ 
Professor of Medicine​ 
Harvard Medical School​ 
Boston, Massachusetts 

Payal K. Patel, MD, MPH, FIDSA​
Systemwide Director of Antimicrobial Stewardship​ 
Associate Professor, Division of Infectious Diseases​ 
Intermountain Health​ 
Salt Lake City, Utah 

Link to full program: 
https://bit.ly/4gu2gcU

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.    

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.